Abstract
Signal transduction has been acknowledged to be involved in various cell biological processes. And it is proved that multiple signaling pathways have been associated with the development and progression of pancreatic cancer, which remains one of the most devastating human diseases. Newly developed drugs targeting these aberrant signaling pathways show bright prospect in improving the therapeutic efficacy and outcome for patients with pancreatic cancer. Here we overview the pancreatic cancer related signaling pathway disorders and the corresponding promising targeted therapeutic regimens.
Keywords: Pancreatic cancer, signal transduction pathway, therapy.
Graphical Abstract
Current Signal Transduction Therapy
Title:Signal Transduction Therapy in Pancreatic Cancer
Volume: 9 Issue: 2
Author(s): Xiaotian Sun, Zhaoshen Li and Min Li
Affiliation:
Keywords: Pancreatic cancer, signal transduction pathway, therapy.
Abstract: Signal transduction has been acknowledged to be involved in various cell biological processes. And it is proved that multiple signaling pathways have been associated with the development and progression of pancreatic cancer, which remains one of the most devastating human diseases. Newly developed drugs targeting these aberrant signaling pathways show bright prospect in improving the therapeutic efficacy and outcome for patients with pancreatic cancer. Here we overview the pancreatic cancer related signaling pathway disorders and the corresponding promising targeted therapeutic regimens.
Export Options
About this article
Cite this article as:
Sun Xiaotian, Li Zhaoshen and Li Min, Signal Transduction Therapy in Pancreatic Cancer, Current Signal Transduction Therapy 2014; 9 (2) . https://dx.doi.org/10.2174/1574362409666141201205149
DOI https://dx.doi.org/10.2174/1574362409666141201205149 |
Print ISSN 1574-3624 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-389X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Angiogenesis Inhibitors and Radiation in Multimodality Cancer Therapy: Preclinical and Clinical Studies
Current Angiogenesis (Discontinued) Targeting the EGFR Pathway for Cancer Therapy
Current Medicinal Chemistry Targeting Prostate Cancer Stem Cells
Anti-Cancer Agents in Medicinal Chemistry Benzofuran-Based Estrogen Receptor α Modulators as Anti-Cancer Therapeutics: In Silico and Experimental Studies
Current Medicinal Chemistry Treatment of Squamous Cell Carcinoma of the Head and Neck in the Metastatic and Refractory Settings: Advances in Chemotherapy and the Emergence of Small Molecule Epidermal Growth Factor Receptor Kinase Inhibitors
Current Cancer Drug Targets Lapatinib as a Dual Tyrosine Kinase Inhibitor Unexpectedly Activates Akt in MDA-MB-231 Triple-Negative Breast Cancer Cells
Letters in Drug Design & Discovery HER2-Mediated Anticancer Drug Delivery: Strategies to Prepare Targeting Ligands Highly Specific for the Receptor
Current Medicinal Chemistry The Development of Copper Radiopharmaceuticals for Imaging and Therapy
Medicinal Chemistry T-DM1 in the Neo-Adjuvant Treatment of HER2-Positive Breast Cancer: Impact of the KRISTINE (TRIO-021) Trial
Reviews on Recent Clinical Trials Natural Carriers for siRNA Delivery
Current Pharmaceutical Design ZnO Nanoparticles Catalyst in the Synthesis of Bioactive Fused Pyrimidines as Anti-breast Cancer Agents Targeting VEGFR-2
Medicinal Chemistry Current Status and Future Prospects of Small–molecule Protein–protein Interaction (PPI) Inhibitors of Tumor Necrosis Factor (TNF) and Receptor Activator of NF-κB Ligand (RANKL)
Current Topics in Medicinal Chemistry Involvement of the Mitochondrial Benzodiazepine Receptor in Traumatic Brain Injury: Therapeutic Implications
CNS & Neurological Disorders - Drug Targets Patented Biomarker Panels in Early Detection of Cancer
Recent Patents on Biomarkers Use of MHC II Structural Features in the Design of Vaccines for Organ-Specific Autoimmune Diseases
Current Pharmaceutical Design Profilin 1 Potentiates Apoptosis Induced by Staurosporine in Cancer Cells
Current Molecular Medicine Modulation of Hepatic MRP3/ABCC3 by Xenobiotics and Pathophysiological Conditions: Role in Drug Pharmacokinetics
Current Medicinal Chemistry Suppression of TLR Signaling by Targeting TIR domain-Containing Proteins
Current Protein & Peptide Science Monitoring of Treatment-Induced Apoptosis in Oncology with PET and SPECT
Current Pharmaceutical Design Histone Deacetylases: Anti-Angiogenic Targets in Cancer Therapy
Current Cancer Drug Targets